Skip to content
value.today

Ingenia Therapeutics Inc.

Total raised
$17 M
3 rounds on record
Latest round
$5 M
Jun 2024
First round on record
Sep 2020
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Ingenia Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2024$5 MNo. 3$2 to $10 million

Ingenia Therapeutics Inc.: Raise no. 3, Jun 2024

Investors in this round

1 investor had bought by the notice of Jun 21, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $25 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sangyeul Han · Executive Officer, Director
  • Eric Furfine · Director
  • Joo Hee Kwak · Director
  • Kwang Ho Cheong · Director
  • Sang Gyun Kim · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sangyeul Han, President. Newest notice filed Jun 21, 2024. Read the notice at the SEC.

equitySEC
Nov 2022$7 MNo. 2$2 to $10 million

Ingenia Therapeutics Inc.: Raise no. 2, Nov 2022

Investors in this round

5 investors had bought by the notice of Nov 30, 2022: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $16 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sangyeul Han · Executive Officer, Director
  • Eric Furfine · Director
  • Heewon Park · Director
  • Sung Jae Kim · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sangyeul Han, President. Newest notice filed Nov 30, 2022. Read the notice at the SEC.

equitySEC
Sep 2020$5 MNo. 1$2 to $10 million

Ingenia Therapeutics Inc.: Raise no. 1, Sep 2020

Investors in this round

9 investors had bought by the notice of Sep 29, 2020: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Minji Kim · Executive Officer, Director
  • Sangyeul Han · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sangyeul Han, President. Newest notice filed Sep 29, 2020. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ingenia Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2024).

    SEC Form D · Jun 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Ingenia Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ingenia Therapeutics Inc.
NameRoleNamed in
Sangyeul HanExecutive officerJun 2024
Minji KimExecutive officerSep 2020
Eric FurfineDirectorJun 2024
Joo Hee KwakDirectorJun 2024
Kwang Ho CheongDirectorJun 2024
Sang Gyun KimDirectorJun 2024
Sangyeul HanDirectorJun 2024
Heewon ParkDirectorNov 2022
Sung Jae KimDirectorNov 2022
Minji KimDirectorSep 2020